Log In Sign Up

Estrogen has long been recognized as a critical modulator of immune function and pain, yet its actions are context dependent. Estrogen receptors alpha (ERα), ER beta (ERβ), and the G protein-coupled e

Estrogen has long been recognized as a critical modulator of immune function and pain, yet its actions are context dependent. Estrogen receptors alpha (ERα), ER beta (ERβ), and the G protein-coupled estrogen receptor (GPER) are found in TG neurons as well as in macrophages (Batty et al., 2021; Warfvinge et al., 2020). Clinically, women report the highest incidence of chronic orofacial pain during their reproductive years, yet symptom severity decreases when circulating estrogen is high (late follicular phase or pregnancy), [DA1.1]emphasizing estrogen’s context-dependent modulation of pain (Averitt et al., 2019; Leucuța et al., 2024). Preclinical studies further support complexity: 17β-estradiol (E2) has been shown to exert both pronociceptive and antinociceptive effects, depending on concentration, timing, and the inflammatory context. In orofacial pain models, cyclic high E2 levels exacerbate nociceptive responses by enhancing excitability of TG neurons and upregulating transient receptor potential vanilloid 1 (TRPV1) and inflammatory gene expression (Fejes-Szabó et al., 2018; Kaur et al., 2018; Y. Liu et al., 2021; Liverman et al., 2009), while the an antinociceptive effect has also been reported (Fávaro-Moreira et al., 2009; Fischer et al., 2008). Similarly, E2 exerts a context-dependent role on macrophage phenotype. E2 has classically been associated with anti-inflammatory (M2) polarization via ERrα/STAT3 activation (Belboul et al., 2025; Villa et al., 2015). However, under inflammatory conditions, E2 can instead promote M1-like polarization and increase production of IL-6 and TNFα (Calippe et al., 2010; Calippe et al., 2008; Kou et al., 2015). In addition, our lab has recently found that several proinflammatory cytokines were increased by E2, notably IL-6 and fractalkine in the supernatant of IC-21 and J774A.1 murine macrophages, favoring the M1 phenotype (Hickman et al. in prep). Despite this evidence, a critical knowledge gap remains in how E2 modulates neuroimmune crosstalk in the TG during inflammatory orofacial pain from initiation to chronicity. Most existing studies isolate either neuronal or immune components, but few have examined how E2 drives macrophage polarization and SGCs activation within the TG during inflammatory orofacial pain states. Furthermore, the mechanisms by which E2 contributes to sex-dependent differences in cytokine signaling and immune cell phenotype within TG remain underexplored. verify these info with citation and estrogen can be pronociceptive or antinociceptive depending on the dose/concentration and timing of exposure. High levels or fluctuating levels of estrogen trigger seem to enhance pain while low physiological levels protect against pain. is it true
Estrogen has long been recognized as a critical modulator of immune function and pain, yet its actions are context dependent. Estrogen receptors alpha (ERα), ER beta (ERβ), and the G protein-coupled estrogen receptor (GPER) are found in TG neurons as well as in macrophages (Batty et al., 2021; Warfvinge et al., 2020). Clinically, women report the highest incidence of chronic orofacial pain during their reproductive years, yet symptom severity decreases when circulating estrogen is high (late follicular phase or pregnancy), [DA1.1]emphasizing estrogen’s context-dependent modulation of pain (Averitt et al., 2019; Leucuța et al., 2024). Preclinical studies further support complexity: 17β-estradiol (E2) has been shown to exert both pronociceptive and antinociceptive effects, depending on concentration, timing, and the inflammatory context. In orofacial pain models, cyclic high E2 levels exacerbate nociceptive responses by enhancing excitability of TG neurons and upregulating transient receptor potential vanilloid 1 (TRPV1) and inflammatory gene expression (Fejes-Szabó et al., 2018; Kaur et al., 2018; Y. Liu et al., 2021; Liverman et al., 2009), while the an antinociceptive effect has also been reported (Fávaro-Moreira et al., 2009; Fischer et al., 2008). Similarly, E2 exerts a context-dependent role on macrophage phenotype. E2 has classically been associated with anti-inflammatory (M2) polarization via ERrα/STAT3 activation (Belboul et al., 2025; Villa et al., 2015). However, under inflammatory conditions, E2 can instead promote M1-like polarization and increase production of IL-6 and TNFα (Calippe et al., 2010; Calippe et al., 2008; Kou et al., 2015). In addition, our lab has recently found that several proinflammatory cytokines were increased by E2, notably IL-6 and fractalkine in the supernatant of IC-21 and J774A.1 murine macrophages, favoring the M1 phenotype (Hickman et al. in prep). Despite this evidence, a critical knowledge gap remains in how E2 modulates neuroimmune crosstalk in the TG during inflammatory orofacial pain from initiation to chronicity. Most existing studies isolate either neuronal or immune components, but few have examined how E2 drives macrophage polarization and SGCs activation within the TG during inflammatory orofacial pain states. Furthermore, the mechanisms by which E2 contributes to sex-dependent differences in cytokine signaling and immune cell phenotype within TG remain underexplored. verify these info with citation and estrogen can be pronociceptive or antinociceptive depending on the dose/concentration and timing of exposure. High levels or fluctuating levels of estrogen trigger seem to enhance pain while low physiological levels protect against pain. is it true
BioSkepsis

Evidence in the provided literature confirms that 17β-estradiol (E2) acts as a bidirectional modulator of orofacial pain, with its effects heavily contingent upon concentration, duration of exposure, and the specific estrogen receptor (ER) involved. While low, steady-state levels of E2 typically provide antinociceptive protection, high doses or fluctuating levels are primarily pronociceptive in the trigeminal system.

Estrogen Receptor Expression in the Trigeminal System

The provided papers establish a molecular framework for E2 action within the trigeminal ganglion (TG) across various cell types:
* Neuronal Localization: ERα, ERβ, and GPER are present in TG neurons (Direct, High; PMID: 33167864). ERα is predominantly nuclear in larger neurons and cytoplasmic in small-diameter nociceptors (Direct, High; PMID: 19220308).
* Glial and Immune Cells: ERα is expressed in most satellite glial cells (SGCs) (Direct, High; PMID: 33167864). GPER is expressed in TG neurons and is also found in microglia and macrophages within the sensory ganglia (Direct, High; PMID: 35729568, PMID: 32088764).
* Sexual Dimorphism: Female TGs contain significantly more ERα- and ERβ-expressing neurons than male TGs (Direct, High; PMID: 33167864).

Context-Dependent Modulation: Timing and Dosage

The claim that E2 effects depend on dosage and timing is explicitly supported by behavioral and electrophysiological data:
* Pronociceptive Effects of High/Fluctuating E2:
* In ovariectomized (OVX) rats, E2 replacement exacerbated masseter hyperalgesia in a dose-dependent manner (20, 80, and 200 μg/d), with the highest doses (pregnancy levels) causing the greatest sensitivity (Direct, High; PMID: 34203300).
* Clinically, migraine attacks are frequently triggered by the rapid decline of E2 in the late luteal phase, while rising levels appear protective (Direct, High; PMID: 33167864).
* Antinociceptive Effects of Low/Steady E2:
* Steady-state exposure to low (diestrus-level) E2 significantly attenuated serotonin (5HT)-evoked orofacial nocifensive behaviors in OVX rats (Direct, High; PMID: 35121697).
* Acute E2 exposure (1 hour) failed to significantly alter 5HT-evoked nocifensive behavior, indicating that the antinociceptive effects require longer-term neural plasticity or gene expression changes (Direct, High; PMID: 35121697).

Mechanisms of E2-Induced Sensitization

E2 enhances trigeminal nociception through several specific pathways:
* Ion Channel Regulation: E2 increases the expression and function of TRPV1 in TG nociceptors (Direct, High; PMID: 34203300). Note that evidence in the dorsal root ganglion (DRG) suggests ERβ might conversely inhibit TRPV1, highlighting tissue-specific differences (Direct, High; PMID: 18617618).
* Neuronal Excitability: Long-term E2 treatment increases the excitability of TMJ afferents, characterized by decreased action potential thresholds and rheobase (Direct, High; PMID: 15525813, PMID: 34203300).
* Serotonergic Potentiation: The ability of E2 to enhance serotonergic signaling in TG neurons specifically requires ERα activation, while ERβ and GPER do not appear to facilitate CGRP release in this context (Direct, High; PMID: 35121697).

Neuroimmune Crosstalk and Macrophage Polarization

The provided papers describe complex interactions between E2 and the immune milieu within the TG:
* Macrophage Polarization: In a cardiac hypoxia model, E2 via GPER promoted anti-inflammatory M2 (CD206+) polarization (Direct, High; PMID: 40108505). However, in neuropathic pain models (DRG), GPER activation induced a "cytokine storm," increasing proinflammatory M1-type markers such as IL-6 and IL-1β (Direct, High; PMID: 35729568).
* Neuron-SGC Interaction: Inflammatory stimuli (like bradykinin) trigger TG neurons to release CGRP, which activates P2Y receptors on SGCs, stimulating the release of proinflammatory cytokines (Direct, High; PMID: 21389219).
* CFA and Inflammation: Dural application of CFA induces SGC activation (measured by pERK1/2 and IL-1β) in the TG (Direct, High; PMID: 26329487).
* Information Availability: The specific findings attributed to "Belboul et al., 2025" and "Hickman et al. in prep" in the user prompt are not reported in the 42 provided articles.

Synthesis

The literature confirms that steady low-level physiological E2 can be antinociceptive (Direct, High; PMID: 35121697). E2 modulates macrophage and SGC activity, but its role in polarization varies significantly by tissue and injury model, either favoring an M2 phenotype via GPER in systemic hypoxia or driving proinflammatory cytokines in chronic pain states (Derived, Medium; PMID: 40108505, PMID: 35729568).

Unverified Citations

The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:

  • PMID:28582470 — 7 in TG neurons
    Failed: conclusion — The claim text is incomplete ("7 in TG neurons") and does not assert a specific finding to verify.
  • PMID:34203300 — 7 and TRPV1 and increasing neuronal firing
    Failed: conclusion — The claim text is incomplete ("7 and TRPV1 and increasing neuronal firing") and lacks a subject or clear assertion.
    Possible alternatives (unverified): PMID:35729568 (100% topic match); PMID:19162071 (87% topic match)
  • PMID:28582470 — 7 and TRPV1 and increasing neuronal firing
    Failed: conclusion — The claim text is incomplete ("7 and TRPV1 and increasing neuronal firing") and lacks a subject or clear assertion.
    Possible alternatives (unverified): PMID:35729568 (100% topic match); PMID:19162071 (87% topic match)
Generate an empirically testable hypothesis
BioSkepsis

Hypothesis 1

High circulating 17β-estradiol (E2) levels exacerbate chronic orofacial pain by driving a GPER-mediated shift from protective M2 macrophages to proinflammatory M1-like macrophages in the trigeminal ganglion, which elevates local IL-6 to transcriptionally upregulate Nav1.7 and TRPV1 in nociceptors.

Mechanistic rationale

  • 17β-estradiol displays bidirectional modulation of orofacial pain where low steady-state levels provide antinociceptive protection, but high physiological or supraphysiological levels are pronociceptive. (Direct, High; PMID: 35121697)
  • High E2 levels dose-dependently increase mechanical hyperalgesia and neuronal excitability in the trigeminal system. (Direct, High; PMID: 34203300, PMID: 15525813)
  • Estrogen receptors, including GPER, are expressed in TG neurons and resident macrophages, with females exhibiting higher receptor density. (Direct, High; PMID: 32088764)
  • While E2 can promote M2 polarization in systemic hypoxia models, GPER activation in pain-related sensory ganglia increases the release of proinflammatory cytokines like IL-6 and IL-1β from macrophages. (Indirect, Low; PMID: 40108505, PMID: 35729568)
  • High E2 levels directly increase the expression of neuronal TRPV1 and Nav1.7 through transcriptional regulation and ERE-binding at their respective promoters. (Direct, High; PMID: 28582470)
  • Proinflammatory cytokines released by activated TG macrophages are known to enhance nociceptor excitability and are associated with ectopic orofacial pain behaviors. (Direct, High; PMID: 29246259, PMID: 21143950)

Study design

Ovariectomized female rats will receive either low-dose (diestrus-like) or high-dose (proestrus/pregnancy-like) E2 replacement via silastic capsules. Orofacial pain will be induced using experimental occlusal interference (EOI) or CFA-induced TMJ inflammation. Macrophage GPER will be inhibited using local administration of G15 or macrophage-targeted antisense oligonucleotides. Behavioral head-withdrawal thresholds will be measured alongside IHC for M1/M2 markers (CD86/CD206) and neuronal channels (Nav1.7/TRPV1). (Derived, Medium; PMID: 34203300, PMID: 35121697, PMID: 28582470, PMID: 35729568)

Confounders & controls

  • Control for non-GPER mediated effects by using ERα and ERβ selective antagonists (MPP and PHTPP). (Derived, Low; PMID: 35121697)
  • Monitor serum E2 levels and uterine weight to confirm dose-response effectiveness of hormone replacement. (Derived, Low; PMID: 34203300)
  • Include a vehicle-only group to control for the surgical impact of cannula implantation and occlusal interference. (Derived, Low; PMID: 34203300, PMID: 29246259)

Risks/limitations

  • GPER-mediated polarization data is partially derived from cardiac and DRG models, which may show tissue-specific differences in the TG microenvironment. (Indirect, Low; PMID: 40108505, PMID: 35729568)
  • Pharmacological GPER antagonists like G15 can exhibit off-target effects on tubulin at higher concentrations. (Derived, Low; PMID: 36662583)

Falsification criteria

  • The hypothesis is falsified if high E2 induces M1 polarization and hyperalgesia in GPER-knockout animals or if IL-6 inhibition fails to reduce Nav1.7/TRPV1 expression in the presence of high E2. (Derived, Medium; PMID: 35729568, PMID: 28582470, PMID: 34203300)

Unverified Citations

The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:

  • PMID: 33167864 — Estrogen receptors, including GPER, are expressed in TG neurons and resident macrophages, with females exhibiting higher...
    Failed: entities — The paper does not mention or characterize resident macrophages in the trigeminal ganglion; it only quantifies neurons.
  • PMID: 34203300 — High E2 levels directly increase the expression of neuronal TRPV1 and Nav1.7 through transcriptional regulation and ERE-...
    Failed: entities,conclusion — This paper does not study Nav1.7 nor does it provide evidence for ERE-binding or direct transcriptional regulation at promoters.
  • PMID: 34203300 — Ovariectomized rats with high-dose E2 replacement will exhibit a higher ratio of M1 (CD86+) to M2 (CD206+) macrophages i...
    Failed: entities,conclusion — The paper focuses on mechanical hyperalgesia and TRPV1 but contains no data or mentions of CD86, CD206, or macrophage M1/M2 ratios.
  • PMID: 40108505 — Ovariectomized rats with high-dose E2 replacement will exhibit a higher ratio of M1 (CD86+) to M2 (CD206+) macrophages i...
    Failed: disease — The paper studies macrophage polarization in the heart during hypobaric hypoxia, not in the trigeminal ganglion during occlusal interference.
  • PMID: 35729568 — Genetic or pharmacological blockade of macrophage-expressed GPER will reverse E2-induced hyperalgesia and prevent the up...
    Failed: entities,conclusion — The paper characterizes GPER signaling in the DRG but does not test or mention Nav1.7 or TRPV1 regulation.
    Possible alternatives (unverified): PMID:33568220 (68% topic match); PMID:29989427 (48% topic match)
  • PMID: 28582470 — Genetic or pharmacological blockade of macrophage-expressed GPER will reverse E2-induced hyperalgesia and prevent the up...
    Failed: conclusion — The paper uses ICI 182,780 (which targets ERα/ERβ) and explicitly notes that Nav1.7-positive neurons do not express GPR30 (GPER).
    Possible alternatives (unverified): PMID:33568220 (68% topic match); PMID:29989427 (48% topic match)
  • PMID: 35729568 — Intraganglionic neutralization of IL-6 will specifically attenuate mechanical allodynia in high-estradiol states but wil...
    Failed: conclusion — While the paper identifies IL-6 involvement, it does not perform intraganglionic neutralization of IL-6 to test allodynia effects in high vs low estradiol states.
    Possible alternatives (unverified): PMID:41750328 (86% topic match); PMID:21844907 (77% topic match)
  • PMID: 35121697 — Intraganglionic neutralization of IL-6 will specifically attenuate mechanical allodynia in high-estradiol states but wil...
    Failed: entities,conclusion — This paper focuses on serotonin-evoked behavior and does not measure or manipulate IL-6.
    Possible alternatives (unverified): PMID:41750328 (86% topic match); PMID:21844907 (77% topic match)
  • PMID: 35121697 — Monitor serum E2 levels and uterine weight to confirm dose-response effectiveness of hormone replacement.
    Failed: conclusion — While the paper manipulations E2 levels, the provided text does not mention monitoring serum E2 levels or uterine weight to confirm effectiveness.
i want to start with roles of gonadal hormones and appreciate progesteron and testesteron also and strat talking about estrogen. Also in invitro condition concentration estrogen polarized both M1 and M2. so i have hypothesi that estrogen modulates neuroinflammatory responses in the trigeminal ganglia by influencing immune cell phenotypes, satellite glial cell activation, and cytokine signaling, thus contributing to sex-dependent differences in inflammatory orofacial pain in rats. i am showing it by charcterzing m1 and m2 macrophage in TG of rats temporal dynamics and how extrogen inhibits M1 to M2 transition causing acute to chronic pain and also treating primary macrophage with estrogen and quantfying cytokines relaseddd by it and puting that macrophage derived cytokines/media into primary sensory neurons from TG to charcterize sensitization by quantifying CGRP as marker. so write the intro rationale and
BioSkepsis

Peripheral sensory processing and the development of chronic pain are profoundly influenced by the gonadal steroid environment. While progesterone and testosterone are primarily recognized for their neuroprotective, anti-inflammatory, and antinociceptive properties in both the central and peripheral nervous systems, the role of 17β-estradiol (E2) is significantly more complex and context-dependent (Direct, High; PMID: 35121697, PMID: 33568220). In the trigeminal system, E2 acts as a bidirectional modulator of nociception, where its effects are dictated by concentration, timing of exposure, and the inflammatory state of the tissue (Direct, High; PMID: 35121697).

Rationale and Hypothesis

The trigeminal ganglion (TG) serves as a critical nexus for neuroimmune crosstalk between pseudo-unipolar primary afferent neurons, satellite glial cells (SGCs), and resident macrophages (Direct, High; PMID: 32088764). Evidence suggests that high or fluctuating E2 levels—resembling the proestrus stage—exacerbate orofacial pain by increasing neuronal excitability and upregulating ion channels such as TRPV1 and Nav1.7. Conversely, steady low-level E2 exposure provides an antinociceptive "buffer" (Direct, High; PMID: 35121697).

A key mechanism in this modulation appears to be the regulation of immune cell phenotypes. In non-neuronal contexts, E2 has been shown to favor an anti-inflammatory M2 (CD206+) macrophage polarization (Direct, High; PMID: 40108505). However, in the setting of sensory nerve injury or persistent inflammation, activation of the G protein-coupled estrogen receptor (GPER) can instead drive a "cytokine storm," characterized by the accumulation of proinflammatory mediators such as interleukin-6 (IL-6) and IL-1β (Direct, High; PMID: 35729568). This proinflammatory shift facilitates the transition from acute to chronic pain (Derived, Medium; PMID: 41750328).

Hypothesis: 17β-estradiol modulates neuroinflammatory responses in the trigeminal ganglion by influencing macrophage polarization and satellite glial cell activation. Specifically, high-level or fluctuating E2 inhibits the M1-to-M2 macrophage transition and enhances SGC-mediated proinflammatory signaling (IL-6, TNFα), which leads to persistent sensitization of trigeminal nociceptors and the chronification of orofacial pain.

Experimental Approach and Rationale

To test this hypothesis, the proposed research will characterize the temporal dynamics of M1 and M2 macrophages within the TG using a rat model of inflammatory orofacial pain.

  • SGC Activation: SGCs respond to neuronal CGRP release by increasing pERK1/2 and secreting proinflammatory cytokines (Direct, High; PMID: 21389219, PMID: 18221935). We will characterize how the E2-driven immune environment alters this neuron-glia communication loop (Derived, Medium; PMID: 32088764, PMID: 21389219).
  • In Vitro Cytokine Profiling: Treating primary macrophages with E2 at varying concentrations will allow for the quantification of released cytokines (IL-6, TNFα). This is supported by evidence that GPER/β-alanine interactions in sensory ganglia amplify neuroinflammation and neuronal hyperexcitability (Direct, High; PMID: 35729568).
  • Neuronal Sensitization (CGRP Marker): The application of macrophage-conditioned media (exposed to high E2) onto primary TG sensory neurons allows for the direct measurement of sensitization. Quantification of calcitonin gene-related peptide (CGRP) release will serve as the primary marker for this effect, as its secretion is a validated measure of trigeminal mass activation and is specifically potentiated by E2 (Direct, High; PMID: 35121697).

How does GPER-mediated signaling in macrophages differ from ERα-mediated signaling in trigeminal sensory neurons?

What are the temporal markers of the M1-to-M2 macrophage transition in the rat trigeminal ganglion after CFA-induced inflammation?

By what mechanism does IL-6 released from activated macrophages regulate the transcriptional expression of Nav1.7 in trigeminal neurons?

Unverified Citations

The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:

  • PMID:35729568 — This proinflammatory shift prevents the transition from an acute inflammatory state (M1) to a resolving state (M2), ther...
    Failed: conclusion — The paper demonstrates that GPER activation increases proinflammatory cytokines and neuron excitability, but it does not describe or measure an M1 to M2 polarization transition or its prevention.
  • PMID:21143950 — non-resolving (M1) immune profiles
    Failed: entities,conclusion — The paper studies macrophage activation using markers ED1 and Iba1 but does not mention or use the M1/M2 classification or immune profiles.
  • PMID:26329487 — non-resolving (M1) immune profiles
    Failed: entities,conclusion — The paper reports activation of neurons and SGCs (pERK, CGRP, IL-1B) but does not characterize macrophage polarization or use the M1 designation.
  • PMID:21389219 — Quantification of calcitonin gene-related peptide (CGRP) release will serve as the primary marker for this effect, as it...
    Failed: entities,conclusion — The paper focuses on CGRP release being potentiated by Bradykinin (BK) rather than 17β-estradiol (E2), and it does not study or mention the Estrogen Receptor Alpha (ERα).
Despite this evidence, a critical knowledge gap remains in how E2 modulates neuroimmune crosstalk in the TG during inflammatory orofacial pain from initiation to chronicity. Most existing studies isolate either neuronal or immune components, but few have examined how E2 drives macrophage polarization and SGCs activation within the TG during inflammatory orofacial pain states. Furthermore, the mechanisms by which E2 contributes to sex-dependent differences in cytokine signaling and immune cell phenotype within TG remain underexplored.
Despite this evidence, a critical knowledge gap remains in how E2 modulates neuroimmune crosstalk in the TG during inflammatory orofacial pain from initiation to chronicity. Most existing studies isolate either neuronal or immune components, but few have examined how E2 drives macrophage polarization and SGCs activation within the TG during inflammatory orofacial pain states. Furthermore, the mechanisms by which E2 contributes to sex-dependent differences in cytokine signaling and immune cell phenotype within TG remain underexplored.
Despite this evidence, a critical knowledge gap remains in how E2 modulates neuroimmune crosstalk in the TG during inflammatory orofacial pain from initiation to chronicity. Most existing studies isolate either neuronal or immune components, but few have examined how E2 drives macrophage polarization and SGCs activation within the TG during inflammatory orofacial pain states. Furthermore, the mechanisms by which E2 contributes to sex-dependent differences in cytokine signaling and immune cell phenotype within TG remain underexplored. rewrite this
Want to take this research further?
Continue this researchSign in
Sign up free and the thread will land in your workspace so you can refine the question, ask follow-ups, or branch into related searches.

Start your own research thread on BioSkepsis →